Zare, S. Y., Lin, L., Alghamdi, A. G., Daehne, S., Roma, A. A., Hasteh, F., . . . Fadare, O. (2019). Breast cancers with a HER2/CEP17 ratio of 2.0 or greater and an average HER2 copy number of less than 4.0 per cell: Frequency, immunohistochemical correlation, and clinicopathological features. Human pathology, 83, 7-13. https://doi.org/10.1016/j.humpath.2018.08.005
Chicago-Zitierstil (17. Ausg.)Zare, Somaye Y., Leo Lin, Abrar G. Alghamdi, Svenja Daehne, Andres A. Roma, Farnaz Hasteh, Marie Dell'Aquila, und Oluwole Fadare. "Breast Cancers with a HER2/CEP17 Ratio of 2.0 or Greater and an Average HER2 Copy Number of Less than 4.0 Per Cell: Frequency, Immunohistochemical Correlation, and Clinicopathological Features." Human Pathology 83 (2019): 7-13. https://doi.org/10.1016/j.humpath.2018.08.005.
MLA-Zitierstil (9. Ausg.)Zare, Somaye Y., et al. "Breast Cancers with a HER2/CEP17 Ratio of 2.0 or Greater and an Average HER2 Copy Number of Less than 4.0 Per Cell: Frequency, Immunohistochemical Correlation, and Clinicopathological Features." Human Pathology, vol. 83, 2019, pp. 7-13, https://doi.org/10.1016/j.humpath.2018.08.005.